XML 25 R13.htm IDEA: XBRL DOCUMENT
v3.21.1

Fair Value Measurements | 3 Months Ended
--- | ---
Mar. 31, 2021
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Fair Value Measurements Topic 820 of the FASB ASC defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Topic 820 also establishes a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: •Level 1 – Quoted prices in active markets for identical assets or liabilities. •Level 2 – Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. •Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. There have been no significant changes to the valuation techniques and inputs used to develop the recurring fair value measurements from those disclosed in our 2020 Annual Report. The following tables present the fair value of assets measured at fair value on a recurring basis as of March 31, 2021 and December 31, 2020 (dollars in thousands):
| As of March 31, 2021
| Fair Value Measured and Recorded Using |  |
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |
Available for sale securities: |  |  |  |  |  |  |
Debt securities: |  |  |  |  |  |  |
U.S. treasury securities | $ | 7,115 |  |  | $ | — |  |  | $ | — |  |  | $ | 7,115 |
Debt securities issued by U.S. federal agencies | — |  |  | 9,489 |  |  | — |  |  | 9,489 |
Corporate debt securities | — |  |  | 50,514 |  |  | — |  |  | 50,514 |
Asset-backed securities | — |  |  | 3,791 |  |  | — |  |  | 3,791 |
Collateralized mortgage obligations | — |  |  | 1,369 |  |  | — |  |  | 1,369 |
Total available for sale debt securities | 7,115 |  |  | 65,163 |  |  | — |  |  | 72,278 |
Equity securities | 44,592 |  |  | — |  |  | — |  |  | 44,592 |
Investments in unconsolidated subsidiaries | — |  |  | — |  |  | 216,939 |  |  | 216,939 |
Warehouse receivables | — |  |  | 686,317 |  |  | — |  |  | 686,317 |
Total assets at fair value | $ | 51,707 |  |  | $ | 751,480 |  |  | $ | 216,939 |  |  | $ | 1,020,126 |
| As of December 31, 2020
| Fair Value Measured and Recorded Using |  |
| Level 1 |  | Level 2 |  | Level 3 |  | Total
Assets |  |  |  |  |  |  |
Available for sale securities: |  |  |  |  |  |  |
Debt securities: |  |  |  |  |  |  |
U.S. treasury securities | $ | 7,270 |  |  | $ | — |  |  | $ | — |  |  | $ | 7,270 |
Debt securities issued by U.S. federal agencies | — |  |  | 10,216 |  |  | — |  |  | 10,216 |
Corporate debt securities | — |  |  | 51,244 |  |  | — |  |  | 51,244 |
Asset-backed securities | — |  |  | 3,801 |  |  | — |  |  | 3,801 |
Collateralized mortgage obligations | — |  |  | 1,369 |  |  | — |  |  | 1,369 |
Total available for sale debt securities | 7,270 |  |  | 66,630 |  |  | — |  |  | 73,900 |
Equity securities | 43,334 |  |  | — |  |  | — |  |  | 43,334 |
Investments in unconsolidated subsidiaries | — |  |  | — |  |  | 50,000 |  |  | 50,000 |
Warehouse receivables | — |  |  | 1,411,170 |  |  | — |  |  | 1,411,170 |
Total assets at fair value | $ | 50,604 |  |  | $ | 1,477,800 |  |  | $ | 50,000 |  |  | $ | 1,578,404 |
We classify one investment as level 3 in the fair value hierarchy which represents an investment in a non-public entity where we elected the fair value option. The carrying value is deemed to approximate the fair value of this investment due to the proximity of the investment date to the balance sheet dates as well as investee-level performance updates. As of March 31, 2021, and December 31, 2020, investments in unconsolidated subsidiaries at fair value using NAV were $92.8 million and $66.3 million, respectively. These investments fall under practical expedient rules that do not require them to be included in the fair value hierarchy and as a result have been excluded from the tables above. There were no significant non-recurring fair value measurements recorded during the three months ended March 31, 2021. The following non-recurring fair value measurements were recorded for the three months ended March 31, 2020 (dollars in thousands):
| Net Carrying Value as of March 31, 2020 |  | Fair Value Measured and Recorded Using |  | Total Impairment Charges for the Three Months Ended March 31, 2020
|  | Level 1 |  | Level 2 |  | Level 3 |
Property and equipment | $ | 10,185 |  |  | $ | — |  |  | $ | — |  |  | $ | 10,185 |  |  | $ | 21,663 |
Goodwill | 418,861 |  |  | — |  |  | — |  |  | 418,861 |  |  | 25,000 |
Other intangible assets | 13,403 |  |  | — |  |  | — |  |  | 13,403 |  |  | 28,508 |
Total | $ | 442,449 |  |  | $ | — |  |  | $ | — |  |  | $ | 442,449 |  |  | $ | 75,171 |
During the three months ended March 31, 2020, we recorded $50.2 million of non-cash asset impairment charges in our Global Workplace Solutions segment and a non-cash goodwill impairment charge of $25.0 million in our Real Estate Investments segment. Primarily as a result of the recent global economic disruption and uncertainty due to Covid-19, we deemed there to be triggering events in the first quarter of 2020 that required testing of goodwill and certain assets for impairment at that time. Based on these tests, we recorded the aforementioned non-cash impairment charges, which were primarily driven by lower anticipated cash flows in certain businesses directly resulting from a downturn in forecasts as well as increased forecast risk due to Covid-19 and changes in our business going forward. These asset impairment charges were included within the line item “Asset impairments” in the accompanying consolidated statements of operations. The fair value measurements employed for our impairment evaluations were based on a discounted cash flow approach. Inputs used in these evaluations included risk-free rates of return, estimated risk premiums, terminal growth rates, working capital assumptions, income tax rates as well as other economic variables. FASB ASC Topic 825, “Financial Instruments” requires disclosure of fair value information about financial instruments, whether or not recognized in the accompanying consolidated balance sheets. Our financial instruments are as follows: •Cash and Cash Equivalents and Restricted Cash – These balances include cash and cash equivalents as well as restricted cash with maturities of less than three months. The carrying amount approximates fair value due to the short-term maturities of these instruments. •Receivables, less Allowance for Doubtful Accounts – Due to their short-term nature, fair value approximates carrying value. •Warehouse Receivables – These balances are carried at fair value. The primary source of value is either a contractual purchase commitment from Freddie Mac or a confirmed forward trade commitment for the issuance and purchase of a Fannie Mae or Ginnie Mae MBS (see Note 3). •Investments in Unconsolidated Subsidiaries – A portion of these investments are carried at fair value as discussed above. •Available for Sale Debt Securities – Primarily held by our wholly-owned captive insurance company, these investments are carried at their fair value. •Equity Securities – Primarily held by our wholly-owned captive insurance company, these investments are carried at their fair value. •Investments Held in Trust - special purpose acquisition company – Funds received as part of the initial public offering of CBRE Acquisition Holdings, Inc. have been deposited in an interest-bearing U.S. based trust account. The funds will be invested only in specified U.S. government treasury bills with a maturity of 180 days or less or in money market funds. The carrying amount approximates fair value due to the short-term maturities of these instruments. •Short-Term Borrowings – The majority of this balance represents outstanding amounts under our warehouse lines of credit of our wholly-owned subsidiary, CBRE Capital Markets, and our revolving credit facility. Due to the short-term nature and variable interest rates of these instruments, fair value approximates carrying value (see Notes 3 and 8). •Senior Term Loans – Based upon information from third-party banks (which falls within Level 2 of the fair value hierarchy), the estimated fair value of our senior term loans was approximately $757.3 million and $772.2 million at March 31, 2021 and December 31, 2020, respectively. Their actual carrying value, net of unamortized debt issuance costs, totaled $766.3 million and $785.7 million at March 31, 2021 and December 31, 2020, respectively (see Note 8). •Senior Notes – Based on dealers’ quotes (which falls within Level 2 of the fair value hierarchy), the estimated fair value of our 4.875% senior notes was $681.1 million and $702.5 million at March 31, 2021 and December 31, 2020, respectively. The actual carrying value of our 4.875% senior notes, net of unamortized debt issuance costs and discount, totaled $594.8 million and $594.5 million at March 31, 2021 and December 31, 2020, respectively. The estimated fair value of our 2.500% senior notes was $475.6 million as of March 31, 2021. The actual carrying value of our 2.500% senior notes, net of unamortized debt issuance costs and discount, totaled $487.3 million at March 31, 2021. On December 28, 2020, we redeemed the $425.0 million aggregate outstanding principal amount of our 5.25% senior notes in full (See Note 8).

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration